Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02988388 · ClinicalTrials.gov registry record
Lung Tissue Research Consortium
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 247
- Enrollment target
NCT02988388: Completed study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT02988388 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 247 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02988388 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 247 participants
- Enrollment target
Study Summary
The LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to researchers within and outside the LTRC. Collections of specimens will be linked to individual clinical data appropriate to the particular disease. The primary goal of the LTRC is to identify participants with suspected lung cancer or metastatic disease who are willing to provide informed consent for research use of their specimens and data. Secondarily, the LTRC investigators intend to collect clinical data, limited exposure data, physiologic studies, and radiographic studies from these participants.
Primary Outcome
A final diagnosis of the participant's lung disease will be rendered by the clinical center PI.
Interventions
- PROCEDURE Lung biopsy/lobectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2017-02-23 |
| Est. Completion | 2019-02-21 |
What the finished NCT02988388 record still lists
NCT02988388 is an observational study that tracks outcomes without assigning an intervention. The registered 247 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Lung biopsy/lobectomy is the first listed.
NCT02988388 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02988388 about?
NCT02988388 is a clinical study titled "Lung Tissue Research Consortium". The LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to researchers within and outside the LTRC. Collections of specimens will be linked to individual clinical data appropriate ...
What is the current status of trial NCT02988388?
This trial is currently completed. The enrollment target is 247 participants. The study started on 2017-02-23. Estimated completion is 2019-02-21.
What interventions are being tested in trial NCT02988388?
The interventions under investigation include: Lung biopsy/lobectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02988388?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04269902 · 247 participants · Phase 3
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- NCT04989803 · 247 participants · Phase 1
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- NCT05521399 · 247 participants
Heart Transplantation - Renewal
- NCT05556824 · 247 participants · Phase 2
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI